Lupin Q4 Results 2024. Fy21 profit at rs 1,216 crore. Presents the key result items, its comparison with the sector peers and its previous 5 quarterly results.
North america sales for q3 fy2024 were inr 18,885 mn, up 1.2% compared to inr 18,666 mn in q2 fy2024; Net profit increases by 18% at rs 460 crore;
Personnel Cost Was 17.9% Of Sales At Inr 7,730 Mn Compared To Inr 7,640 Mn In Q3 Fy2023.
Investors watched the performance of players like dcm shriram, godrej consumer products, lupin, marico, happiest minds.
Up 23.7% As Compared To Inr.
Fda for travoprost ophthalmic solution usp may 3, 2024 lupin launches.
India Formulation Sales For Fy 2024 Were Inr 66,564 Mn, Up 9.6% As Compared To Inr 60,759 Mn In Fy2023;
Images References :
2 Min Read 09 May 2023, 11:47 Pm Ist Trade Now.
Fy21 profit at rs 1,216 crore.
Accounting For 34% Of Lupinโs Global Sales.
North america sales for q1 fy2024 were inr 15,905 mn, up 2.6% compared to inr 15,503 mn in q4 fy2023;
Lupin Is Expected To Log Earnings Before Interest, Taxes,.